Overview and Epidemiology

Catheter-Associated Urinary Tract Infection (CAUTI) is defined as a urinary tract infection where an indwelling urinary catheter was in place during the patient’s hospitalization or upon admission, or was inserted within the preceding 48 hours. CAUTIs represent a significant burden on healthcare systems, accounting for approximately 75% of all hospital-acquired UTIs and contributing substantially to increased morbidity, mortality, and healthcare costs.

The primary driver of CAUTI is the breach of the urothelial barrier provided by the catheter, which serves as a conduit for ascending microbial migration.

Pathophysiology and Risk Factors

CAUTI pathogenesis typically involves two mechanisms: extraluminal ascent (bacteria migrating along the outside of the catheter via the periurethral plane) and intraluminal ascent (bacteria traveling through the catheter lumen or around the balloon cuff).

Key Clinical Risk Factors:

• Duration of Catheterization: The single greatest risk factor. The risk of infection increases exponentially after 48 hours of catheterization.
• Aseptic Technique Failure: Breakdowns in sterile technique during insertion.
• Biofilm Formation: Bacteria adhere to the catheter surface, forming complex extracellular polymeric substances (biofilms) that protect microbes from both host immune responses and antibiotic penetration.
• Impaired Urinary Drainage: Kinking of the tubing or bladder spasms can cause urinary stasis, promoting bacterial proliferation.
• Patient Factors: Advanced age, female gender (shorter urethra), neurological impairment (neurogenic bladder), and immunocompromised states.

Clinical Presentation: The Challenge of Asymptomatic Bacteriuria

A critical clinical distinction must be made between Asymptomatic Bacteriuria (ASB) and Symptomatic CAUTI.

Note: Routine screening for ASB in catheterized patients is not recommended unless the patient is undergoing invasive urologic procedures, as treating ASB does not reduce the risk of bloodstream infections but significantly increases the risk of antibiotic resistance and C. difficile infection.

Signs and Symptoms of Symptomatic CAUTI:

Clinical presentation can be non-specific, particularly in elderly or immunocompromised patients where “atypical” presentations (e.g., sudden onset delirium/altered mental status) may predominate.

• Systemic Symptoms: Fever (>38°C/100.4°F), chills, tachycardia, hypotension (suggesting sepsis), and malaise.
• Localizing Symptoms: Suprapubic pain, flank pain (suggesting pyelonephritis), dysuria, or urgency.
• Urine Characteristics: Turbidity, hematuria, or malodorous urine. Note: Cloudy urine alone is insufficient for diagnosis without systemic symptoms.

Diagnostic Workup

Diagnosis should be based on clinical findings supported by microbiology.

1. Microbiology (Gold Standard):
   • Urine Culture: A single specimen obtained via an aseptic technique (using a needleless connector or catheter port) is required.
   • Interpretation: While “standard” thresholds exist, clinicians should prioritize the identification of pathogens and their sensitivity patterns. In catheterized patients, even lower colony counts may be clinically significant if symptoms are present.
2. Urinalysis (UA): May show pyuria (WBC >5/HPF) and bacteriuria. However, pyuria in a catheterized patient is often due to inflammation or colonization rather than active infection; therefore, UA should not be used as the sole diagnostic tool for CAUTI.
3. Imaging: Renal ultrasound or CT may be indicated if pyelonephritis is suspected or if there is an obstruction (e.g., bladder calculi or prostatic hypertrophy) contributing to stasis.

Microbiological Profile

Common pathogens include:

• Gram-negative bacilli: Escherichia coli (most common), Pseudomonas aeruginosa, Klebsiella pneumoniae, and Proteus mirabilis.
• Gram-positive cocci: Enterococcus spp., Staphylococcus saprophyticus.
• Fungal pathogens: Candida species (increasingly prevalent in patients with prolonged catheterization, diabetes, or recent broad-spectrum antibiotic use).

Management and Treatment Strategies

1. Immediate Intervention: Catheter Management

The most critical step in treating CAUTI is the removal or replacement of the indwelling catheter. If the catheter is left in place, the biofilm remains a reservoir for infection, making eradication difficult.

2. Pharmacotherapy

Antibiotic selection should be guided by local antibiograms and patient-specific risk factors (e.ing., history of MDROs).

• Empiric Therapy: Should target common Gram-negative pathogens.
  • For stable patients: Fluoroquinolones or Aminoglycosides (if appropriate) may be considered, though resistance patterns vary.
  • For suspected severe infection/sepsis: Broad-spectrum agents such as Piperacillin-tazobactam or Carbapenems are often indicated.
• Targeted Therapy: Once culture and sensitivity results are available, de-escalate to the narrowest-spectrum agent effective against the isolate.
• Duration: Short courses (3–7 days) are generally sufficient for uncomplicated CAUTI in stable patients. Longer courses may be required for complicated cases or those with deep tissue involvement (e.g., abscess).

Prevention: Evidence-Based Bundles

Prevention is centered on “Catheter Stewardship.”

• Avoidance: Only catheterize when absolutely necessary (e.g., acute urinary retention, end-of-life care, accurate output monitoring in critically ill patients).
• Insertion: Use strict aseptic technique and appropriate lubrication.
• Maintenance (The Bundle):
  • Maintain a closed drainage system at all times.
    • Ensure the collection bag is below the level of the bladder to prevent reflux.
  • Perform daily perineal hygiene with soap and water (avoid harsh antiseptic cleansers unless indicated).
  • Regularly assess the necessity of the catheter; “remove it if you can, leave it if you must.”
• Routine Replacement: While guidelines vary on routine replacement, many institutions recommend replacing catheters every 2–4 weeks or when clinically indicated to prevent biofilm buildup.

Summary for Clinical Practice

When managing a patient with suspected CAUTI: Remove the catheter, assess for sepsis, culture the urine (via the catheter port), and initiate targeted antibiotic therapy. Always prioritize prevention through rigorous catheter stewardship to mitigate the risks of multi-drug resistant organisms and systemic complications.